First human tests begin for experimental drug CIT-013
Knowledge-focused
Not yet recruiting
This early-stage study aims to check the safety and how the body processes CIT-013, an experimental drug given by injection. It will involve 10 healthy adults who will receive either the drug or a placebo. The main goal is to see what side effects occur and how the drug moves thr…
Phase: PHASE1 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC